Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases.
J Neuroimmunol
; 359: 577674, 2021 10 15.
Article
in English
| MEDLINE | ID: covidwho-1330985
ABSTRACT
Acute disseminated encephalomyelitis (ADEM) has been reported after coronavirus disease 2019 (COVID-19). In this review, we systematically included worldwide reported cases on this association. We included 30 case reports (pediatric and adults) and explored epidemiological and clinical evidence. We described time to diagnosis, clinical, imaging, and laboratory features, response to treatment regimens, and differences regarding severity. Also, an original case report was presented. Neurologists must be alert to the occurrence of multifocal neurological symptoms with or without encephalopathy in patients recovered from COVID-19. Timely MRI studies should be performed to establish the diagnosis and to consider early corticosteroid-based treatment.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Global Health
/
Encephalomyelitis, Acute Disseminated
/
COVID-19
Type of study:
Case report
/
Observational study
/
Prognostic study
/
Reviews
/
Systematic review/Meta Analysis
Topics:
Long Covid
/
Vaccines
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
J Neuroimmunol
Year:
2021
Document Type:
Article
Affiliation country:
J.jneuroim.2021.577674
Similar
MEDLINE
...
LILACS
LIS